Harrow Capex To Revenue from 2010 to 2024

HROWM Stock   26.35  0.14  0.53%   
Harrow Health, Capex To Revenue yearly trend continues to be very stable with very little volatility. Capex To Revenue is likely to drop to 0.01. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.01121412
Current Value
0.0107
Quarterly Volatility
0.87399496
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harrow Health, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health,'s main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 6.14, Dividend Yield of 2.0E-4 or PTB Ratio of 19.83. Harrow financial statements analysis is a perfect complement when working with Harrow Health, Valuation or Volatility modules.
  
Check out the analysis of Harrow Health, Correlation against competitors.

Latest Harrow Health,'s Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Harrow Health, 11875 over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Harrow Health,'s Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health,'s overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Harrow Capex To Revenue Regression Statistics

Arithmetic Mean0.61
Geometric Mean0.15
Coefficient Of Variation143.78
Mean Deviation0.74
Median0.10
Standard Deviation0.87
Sample Variance0.76
Range1.9896
R-Value(0.79)
Mean Square Error0.31
R-Squared0.63
Significance0.0004
Slope(0.15)
Total Sum of Squares10.69

Harrow Capex To Revenue History

2024 0.0107
2023 0.0112
2022 0.0877
2021 0.22
2020 0.0203
2019 0.0359
2018 0.0532

About Harrow Health, Financial Statements

Harrow Health, investors utilize fundamental indicators, such as Capex To Revenue, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capex To Revenue 0.01  0.01 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Harrow Health, 11875 is a strong investment it is important to analyze Harrow Health,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health,'s future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:
Check out the analysis of Harrow Health, Correlation against competitors.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.